Of 495 patients tested with gene panels, 459 patients were tested for hotspots in EGFR, KRAS/NRAS, and BRAF, and 36 patients were tested with a larger panel containing hotspots for 14 genes (including the four genes mentioned above) and lung cancer gene fusions. This evidence concerns the gene NRAS and lung carcinoma.